Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2012

Study Completion Date

December 31, 2013

Conditions
Adult Primary Liver CancerHepatitis C Infection
Interventions
DRUG

S-adenosyl-L-methionine disulfate p-toluene-sulfonate

Given PO

OTHER

placebo

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

immunoenzyme technique

Correlative studies

OTHER

high performance liquid chromatography

Correlative studies

Trial Locations (5)

85724

University of Arizona Health Sciences Center, Tucson

90073

Veterans Administration Los Angeles Healthcare System, Los Angeles

90822

Veterans Administration Long Beach Medical Center, Long Beach

92103

University of California At San Diego, San Diego

92868

Chao Family Comprehensive Cancer Center, Orange

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Chao Family Comprehensive Cancer Center

OTHER

NCT00513461 - Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection | Biotech Hunter | Biotech Hunter